The necessity of gastric mucosal biopsy in dyspeptic patients with normal upper endoscopy in Modarres hospital 2017-2018
Novelty in Biomedicine,
Vol. 8 No. 2 (2020),
14 June 2020
,
Page 77-86
https://doi.org/10.22037/nbm.v1i1.27469
Abstract
Background: Considering the diagnostic and therapeutic costs of patients with dyspepsia and the importance of diagnosis during gastrointestinal malignancies, in this study, we investigated the necessity of gastric mucosal biopsy in dyspeptic patients with normal upper endoscopy in Modarres hospital and their 6 months follow up. We studied their endoscopic biopsies changes and some of the involved risk factors this duration.Materials and Methods: In this clinical trial study, 115 patients with dyspepsia, were referred from gastroenterology clinic of Modarres hospital during 2017-2018, were evaluated. Patients were enrolled in a study that did not have any ulcer and mass or deep mucosal lesion in the early endoscopy Surface erosions were no exception and could be included. Five biopsy samples were obtained from different stomach sites. After the pathology results, the patients who had malignancy reports, excluded from the study and other patients were treated with anti-acid drugs and, if necessary, eradicated Helicobacter pylori. After 6 months, they were again subjected to endoscopy and biopsies were taken. Data were analyzed by SPSS software version 22.
Results: The rate of Helicobacter pylori in patients with endoscopic dyspepsia without mucosal lesions after 6 months of treatment was reduced compared to pre-treatment p<0.05, 20.9% vs 12.2%. The severity of chronic gastritis mild to moderate in patients with endoscopic dyspepsia without mucosal lesions after 6 months of treatment was reduced compared to pre-treatment p<0.05, 89.6% vs 80%. There was a significant difference between metaplasia in patients with endoscopic dyspepsia without mucosal lesions before and 6 months after treatment p<0.05, 33%, vs 20%. Female gender, negative family history of GI cancer and not using alcohol were factors that significantly improved the results of biopsy chronic gastritis/ H. pylori /metaplasia after 6 months.
Conclusion: Regarding the reduction in the severity of chronic gastritis, Helicobacter pylori and metaplasia in this group of patients after 6 months of treatment, it is recommended that refraining from unnecessary follow-up and biopsy and imposing cost to the patient and the medical system and be limited to high-risk groups.
- Dyspepsia
- Endoscopy
- Helicobacter pylori
- Chronic Gastritis
- Metaplasia.
How to Cite
References
Moghimi-Dehkordi B, Vahedi M, Khoshkrood Mansoori B, Kasaeian A, Safaee A, Habibi M, et al. Economic burden of gastrooesophageal reflux disease and dyspepsia: A community-basedstudy. Arab J Gastroenterol 2011;12:86–9.
Correa P. Human gastric carcinogenesis: amultistep and multifactorial process-FirstAmerican Cancer Society Award Lecture onCancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-40.
Talley NJ, Vakil N. Guidelines for the ocio demo of dyspepsia. Am J Gastroenterol. 2005;100:2324-37.
North of England dyspepsia guideline development group. Dyspepsia: managing dyspepsia in adults in primary care. Newcastle upon Tyne UK: Centre for Health Services Research, University of Newcastle; 2004.
Jones MP. Evaluation and treatment of dyspepsia.Postgrad Med J. 2003;79:25-9.
R H Jones, Approach to uninvestigated dyspepsia. Gut. 2002;50:iv42-6.
Knill J. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol. 1991;26:17-24.
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, ocio demography, and health impact. Dig Dis Sci. 1993;38:1569-80.
Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998;114:582–95.
Talley NJ. American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129:1753-57.
Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med 2001;134:815-19.
-Hosseini SN, Mousavinasab SN, Moghimi MH, FallahR. Delay in diagnosis and treatment of gastric cancer: from the beginning of symptoms to surgery–an Iranian study. Turk J Gastroenterol. 2007;18:77-81.
Maconi G, Kurihara H, Panizzo V, et al. Gastric cancer in young patients with no alarm symptoms:focus on delay in diagnosis, stage of neoplasm and survival.Scand J Gastroenterol.2003; 38: 1249-55.
-Arents NL A, Thijs JC, Kleibuker JH. A rational approach to uninvestigated dyspepsia in primary care: review of the litherature. Postgrade Med J. 2009;78:707-16.
Ltfi A,Khan MA, Zuberi SJ. Non-endoscopic gastric mucosal biopsy in dyspepsia. J Pak Med Assoc. 2003;53:432-3.
Waldum HL, Kleveland PM, Sørdal ØF. Helicobacter pylori and gastric acid: an intimate and reciprocal relationship. Therapeutic advances in gastroenterology. 2016;96:836-44.
Axon AT. Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion. Advances in Medical Sciences De Gruyter Open. 2007;52.
Rosenthal M. Normal’ Stomach on Endoscopy May Be Anything ButPrecautionary biopsies make sense. 2015. https://www.gastroendonews.com/Article/PrintArticle?articleID=29202.
Goldstein NS. Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients. Modern Pathology. 2000;13(10):1072.
Yang YX, Brill J, Krishnan P, Leontiadis G, Adams MA, Dorn SD, Dudley-Brown SL, Flamm SL, Gellad ZF, Gruss CB, Kosinski LR. American Gastroenterological Association Institute Guideline on the role of upper gastrointestinal biopsy to evaluate dyspepsia in the adult patient in the absence of visible mucosal lesions. Gastroenterology. 2015;149(4):1082-7.
Pinto‐Sanchez MI, Yuan Y, Hassan A, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. The Cochrane Library. 2017 Jan 1.
Yalçin M, Yalçin A, Bengi G, Nak SG. Helicobacter pylori Infection among Patients with Dyspepsia and Intrafamilial Transmission. Euroasian journal of hepato-gastroenterology. 2016;6(2):93.
Kim SE, Park YS, Kim N, Kim MS, Jo HJ, Shin CM, et al. Effect of Helicobacter pylori eradication on functional dyspepsia. Journal of neurogastroenterology and motility. 2013;19(2):233.
Mansour-Ghanaei F, Taefeh N, Joukar F, Besharati S, Naghipour M, Nassiri R. Recurrence of Helicobacter pylori infection 1 year after successful eradication: a prospective study in Northern Iran. Medical Science Monitor. 2010;16(3):CR144-8.
Tirgar Fakheri H, Eshqi F. The Recurrence Rate of Helicobacter Pylori Infection 2 Years After Eradication. J Mazandaran Univ Med Sci. 2007;17(58):72-8.
Gunaid AA, Hassan NA, Murray-Lyon IM. Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen. European journal of gastroenterology & hepatology. 2004;16(12):1309-14.
Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, et al. The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Alimentary pharmacology & therapeutics. 2003;18(2):245-52.
Kyzekove J, Arlt J, Arltova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?. Hepato-gastroenterology. 2001;48(38):594-602.
Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53(9):1244-9.
Felley C, Bouzourene H, VanMelle MB, Hadengue A, Michetti P, Dorta G, et al. Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia. World Journal of Gastroenterology: WJG. 2012;18(17):2076.
- Abstract Viewed: 174 times
- PDF Downloaded: 205 times